nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—Lactic dehydrogenase activity increased—Mesalazine—Crohn's disease	0.0341	0.0455	CcSEcCtD
Nimodipine—Blood lactate dehydrogenase increased—Mesalazine—Crohn's disease	0.03	0.0401	CcSEcCtD
Nimodipine—Gastrointestinal symptom NOS—Mesalazine—Crohn's disease	0.0296	0.0396	CcSEcCtD
Nimodipine—Platelet count decreased—Mesalazine—Crohn's disease	0.0293	0.0392	CcSEcCtD
Nimodipine—Acne—Mesalazine—Crohn's disease	0.0207	0.0277	CcSEcCtD
Nimodipine—Phosphatase alkaline increased—Mesalazine—Crohn's disease	0.0174	0.0233	CcSEcCtD
Nimodipine—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.017	0.0227	CcSEcCtD
Nimodipine—Immune system disorder—Mercaptopurine—Crohn's disease	0.0146	0.0195	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.0145	0.0194	CcSEcCtD
Nimodipine—CACNB3—mammalian vulva—Crohn's disease	0.0137	0.0982	CbGeAlD
Nimodipine—Anaemia—Mercaptopurine—Crohn's disease	0.013	0.0173	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.0127	0.0169	CcSEcCtD
Nimodipine—NR3C2—Preimplantation Embryo—SOX11—Crohn's disease	0.0121	0.108	CbGpPWpGaD
Nimodipine—CACNB3—digestive system—Crohn's disease	0.012	0.0861	CbGeAlD
Nimodipine—Liver function test abnormal—Mesalazine—Crohn's disease	0.0117	0.0156	CcSEcCtD
Nimodipine—Oedema—Mercaptopurine—Crohn's disease	0.0115	0.0153	CcSEcCtD
Nimodipine—Cramp muscle—Mesalazine—Crohn's disease	0.0114	0.0152	CcSEcCtD
Nimodipine—AHR—smooth muscle tissue—Crohn's disease	0.0113	0.0808	CbGeAlD
Nimodipine—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.0112	0.015	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.0112	0.0149	CcSEcCtD
Nimodipine—Acne—Prednisone—Crohn's disease	0.011	0.0147	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.0104	0.014	CcSEcCtD
Nimodipine—AHR—mammalian vulva—Crohn's disease	0.0102	0.0727	CbGeAlD
Nimodipine—Hepatobiliary disease—Azathioprine—Crohn's disease	0.0101	0.0135	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00989	0.0132	CcSEcCtD
Nimodipine—Depression—Mesalazine—Crohn's disease	0.00972	0.013	CcSEcCtD
Nimodipine—Jaundice—Mesalazine—Crohn's disease	0.00951	0.0127	CcSEcCtD
Nimodipine—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00922	0.0123	CcSEcCtD
Nimodipine—AHR—digestive system—Crohn's disease	0.00892	0.0638	CbGeAlD
Nimodipine—Fluid retention—Prednisone—Crohn's disease	0.00876	0.0117	CcSEcCtD
Nimodipine—Hepatitis—Mesalazine—Crohn's disease	0.00875	0.0117	CcSEcCtD
Nimodipine—Immune system disorder—Azathioprine—Crohn's disease	0.00868	0.0116	CcSEcCtD
Nimodipine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00844	0.0113	CcSEcCtD
Nimodipine—CACNA1C—smooth muscle tissue—Crohn's disease	0.00827	0.0591	CbGeAlD
Nimodipine—Cardiac disorder—Mesalazine—Crohn's disease	0.00812	0.0109	CcSEcCtD
Nimodipine—CACNB2—digestive system—Crohn's disease	0.00809	0.0578	CbGeAlD
Nimodipine—Angiopathy—Mesalazine—Crohn's disease	0.00794	0.0106	CcSEcCtD
Nimodipine—Immune system disorder—Mesalazine—Crohn's disease	0.00791	0.0106	CcSEcCtD
Nimodipine—Diarrhoea—Mercaptopurine—Crohn's disease	0.00784	0.0105	CcSEcCtD
Nimodipine—Anaemia—Azathioprine—Crohn's disease	0.00773	0.0103	CcSEcCtD
Nimodipine—NR3C2—smooth muscle tissue—Crohn's disease	0.00753	0.0538	CbGeAlD
Nimodipine—Cardiac failure congestive—Prednisone—Crohn's disease	0.00738	0.00987	CcSEcCtD
Nimodipine—Muscle spasms—Mesalazine—Crohn's disease	0.00733	0.00979	CcSEcCtD
Nimodipine—Vomiting—Mercaptopurine—Crohn's disease	0.00729	0.00974	CcSEcCtD
Nimodipine—Rash—Mercaptopurine—Crohn's disease	0.00723	0.00966	CcSEcCtD
Nimodipine—Dermatitis—Mercaptopurine—Crohn's disease	0.00722	0.00965	CcSEcCtD
Nimodipine—CACNB1—lymph node—Crohn's disease	0.00717	0.0513	CbGeAlD
Nimodipine—Myalgia—Azathioprine—Crohn's disease	0.00712	0.00952	CcSEcCtD
Nimodipine—Anaemia—Mesalazine—Crohn's disease	0.00704	0.00941	CcSEcCtD
Nimodipine—CACNB3—lymph node—Crohn's disease	0.00688	0.0492	CbGeAlD
Nimodipine—Nausea—Mercaptopurine—Crohn's disease	0.00681	0.0091	CcSEcCtD
Nimodipine—NR3C2—mammalian vulva—Crohn's disease	0.00678	0.0484	CbGeAlD
Nimodipine—Palpitations—Mesalazine—Crohn's disease	0.00673	0.009	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.0067	0.00895	CcSEcCtD
Nimodipine—Thrombocytopenia—Azathioprine—Crohn's disease	0.00669	0.00894	CcSEcCtD
Nimodipine—Hypertension—Mesalazine—Crohn's disease	0.00658	0.00879	CcSEcCtD
Nimodipine—CACNA1C—digestive system—Crohn's disease	0.00653	0.0467	CbGeAlD
Nimodipine—Myalgia—Mesalazine—Crohn's disease	0.00649	0.00867	CcSEcCtD
Nimodipine—Hypotension—Azathioprine—Crohn's disease	0.00638	0.00853	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00622	0.00831	CcSEcCtD
Nimodipine—Oedema—Mesalazine—Crohn's disease	0.00622	0.00831	CcSEcCtD
Nimodipine—Nervous system disorder—Mesalazine—Crohn's disease	0.0061	0.00815	CcSEcCtD
Nimodipine—Thrombocytopenia—Mesalazine—Crohn's disease	0.00609	0.00814	CcSEcCtD
Nimodipine—Tachycardia—Mesalazine—Crohn's disease	0.00607	0.00811	CcSEcCtD
Nimodipine—Hyperhidrosis—Mesalazine—Crohn's disease	0.00601	0.00804	CcSEcCtD
Nimodipine—NR3C2—digestive system—Crohn's disease	0.00594	0.0425	CbGeAlD
Nimodipine—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00591	0.00789	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.0059	0.00788	CcSEcCtD
Nimodipine—Hypotension—Mesalazine—Crohn's disease	0.00581	0.00777	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00567	0.00757	CcSEcCtD
Nimodipine—Sweating increased—Prednisone—Crohn's disease	0.00564	0.00753	CcSEcCtD
Nimodipine—Dyspnoea—Mesalazine—Crohn's disease	0.00555	0.00741	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00537	0.00718	CcSEcCtD
Nimodipine—Depression—Prednisone—Crohn's disease	0.00514	0.00688	CcSEcCtD
Nimodipine—AHR—lymph node—Crohn's disease	0.0051	0.0364	CbGeAlD
Nimodipine—Hypersensitivity—Azathioprine—Crohn's disease	0.00503	0.00672	CcSEcCtD
Nimodipine—AHR—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	0.005	0.0447	CbGpPWpGaD
Nimodipine—Bradycardia—Prednisone—Crohn's disease	0.00472	0.0063	CcSEcCtD
Nimodipine—CACNA1F—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA4—Crohn's disease	0.00471	0.0421	CbGpPWpGaD
Nimodipine—Diarrhoea—Azathioprine—Crohn's disease	0.00467	0.00624	CcSEcCtD
Nimodipine—CACNB2—lymph node—Crohn's disease	0.00462	0.033	CbGeAlD
Nimodipine—Hypersensitivity—Mesalazine—Crohn's disease	0.00458	0.00612	CcSEcCtD
Nimodipine—Dizziness—Azathioprine—Crohn's disease	0.00452	0.00604	CcSEcCtD
Nimodipine—Pruritus—Mesalazine—Crohn's disease	0.0044	0.00588	CcSEcCtD
Nimodipine—Vomiting—Azathioprine—Crohn's disease	0.00434	0.0058	CcSEcCtD
Nimodipine—Rash—Azathioprine—Crohn's disease	0.00431	0.00575	CcSEcCtD
Nimodipine—Dermatitis—Azathioprine—Crohn's disease	0.0043	0.00575	CcSEcCtD
Nimodipine—Flushing—Prednisone—Crohn's disease	0.0043	0.00575	CcSEcCtD
Nimodipine—Headache—Azathioprine—Crohn's disease	0.00428	0.00572	CcSEcCtD
Nimodipine—Diarrhoea—Mesalazine—Crohn's disease	0.00426	0.00569	CcSEcCtD
Nimodipine—Angiopathy—Prednisone—Crohn's disease	0.0042	0.00562	CcSEcCtD
Nimodipine—Immune system disorder—Prednisone—Crohn's disease	0.00418	0.00559	CcSEcCtD
Nimodipine—Dizziness—Mesalazine—Crohn's disease	0.00411	0.0055	CcSEcCtD
Nimodipine—Nausea—Azathioprine—Crohn's disease	0.00406	0.00542	CcSEcCtD
Nimodipine—CACNA1D—lymph node—Crohn's disease	0.00404	0.0289	CbGeAlD
Nimodipine—Vomiting—Mesalazine—Crohn's disease	0.00395	0.00529	CcSEcCtD
Nimodipine—Rash—Mesalazine—Crohn's disease	0.00392	0.00524	CcSEcCtD
Nimodipine—Dermatitis—Mesalazine—Crohn's disease	0.00392	0.00524	CcSEcCtD
Nimodipine—Headache—Mesalazine—Crohn's disease	0.0039	0.00521	CcSEcCtD
Nimodipine—AHR—Circadian rythm related genes—CREM—Crohn's disease	0.0038	0.034	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—ZMIZ1—Crohn's disease	0.00378	0.0337	CbGpPWpGaD
Nimodipine—CACNA1C—lymph node—Crohn's disease	0.00373	0.0267	CbGeAlD
Nimodipine—Anaemia—Prednisone—Crohn's disease	0.00373	0.00498	CcSEcCtD
Nimodipine—Nausea—Mesalazine—Crohn's disease	0.00369	0.00494	CcSEcCtD
Nimodipine—Hypertension—Prednisone—Crohn's disease	0.00348	0.00465	CcSEcCtD
Nimodipine—Myalgia—Prednisone—Crohn's disease	0.00343	0.00459	CcSEcCtD
Nimodipine—NR3C2—lymph node—Crohn's disease	0.0034	0.0243	CbGeAlD
Nimodipine—CACNB4—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA4—Crohn's disease	0.00332	0.0296	CbGpPWpGaD
Nimodipine—Oedema—Prednisone—Crohn's disease	0.00329	0.0044	CcSEcCtD
Nimodipine—Nervous system disorder—Prednisone—Crohn's disease	0.00323	0.00431	CcSEcCtD
Nimodipine—CYP3A5—digestive system—Crohn's disease	0.00321	0.023	CbGeAlD
Nimodipine—Tachycardia—Prednisone—Crohn's disease	0.00321	0.00429	CcSEcCtD
Nimodipine—Hyperhidrosis—Prednisone—Crohn's disease	0.00318	0.00425	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.003	0.00401	CcSEcCtD
Nimodipine—CACNB3—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA4—Crohn's disease	0.00265	0.0237	CbGpPWpGaD
Nimodipine—CACNB1—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA4—Crohn's disease	0.00258	0.023	CbGpPWpGaD
Nimodipine—Hypersensitivity—Prednisone—Crohn's disease	0.00242	0.00324	CcSEcCtD
Nimodipine—CYP3A4—digestive system—Crohn's disease	0.00241	0.0172	CbGeAlD
Nimodipine—Pruritus—Prednisone—Crohn's disease	0.00233	0.00311	CcSEcCtD
Nimodipine—Diarrhoea—Prednisone—Crohn's disease	0.00225	0.00301	CcSEcCtD
Nimodipine—Dizziness—Prednisone—Crohn's disease	0.00218	0.00291	CcSEcCtD
Nimodipine—AHR—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	0.00215	0.0192	CbGpPWpGaD
Nimodipine—Vomiting—Prednisone—Crohn's disease	0.00209	0.0028	CcSEcCtD
Nimodipine—Rash—Prednisone—Crohn's disease	0.00207	0.00277	CcSEcCtD
Nimodipine—Dermatitis—Prednisone—Crohn's disease	0.00207	0.00277	CcSEcCtD
Nimodipine—AHR—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	0.00206	0.0184	CbGpPWpGaD
Nimodipine—Headache—Prednisone—Crohn's disease	0.00206	0.00276	CcSEcCtD
Nimodipine—Nausea—Prednisone—Crohn's disease	0.00195	0.00261	CcSEcCtD
Nimodipine—AHR—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	0.00192	0.0171	CbGpPWpGaD
Nimodipine—CACNA1S—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA4—Crohn's disease	0.00189	0.0169	CbGpPWpGaD
Nimodipine—CACNA1F—Alzheimers Disease—IL1B—Crohn's disease	0.0018	0.016	CbGpPWpGaD
Nimodipine—AHR—Adipogenesis—SOCS1—Crohn's disease	0.00178	0.0159	CbGpPWpGaD
Nimodipine—CACNB4—NCAM signaling for neurite out-growth—TYK2—Crohn's disease	0.00171	0.0153	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—TAB1—Crohn's disease	0.0017	0.0152	CbGpPWpGaD
Nimodipine—CACNB4—NCAM signaling for neurite out-growth—JAK2—Crohn's disease	0.00163	0.0146	CbGpPWpGaD
Nimodipine—CACNB2—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA4—Crohn's disease	0.00162	0.0145	CbGpPWpGaD
Nimodipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA4—Crohn's disease	0.00153	0.0137	CbGpPWpGaD
Nimodipine—AHR—Adipogenesis—SMAD3—Crohn's disease	0.00153	0.0137	CbGpPWpGaD
Nimodipine—AHR—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	0.00139	0.0124	CbGpPWpGaD
Nimodipine—AHR—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	0.00139	0.0124	CbGpPWpGaD
Nimodipine—CACNB3—NCAM signaling for neurite out-growth—TYK2—Crohn's disease	0.00137	0.0122	CbGpPWpGaD
Nimodipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA4—Crohn's disease	0.00135	0.012	CbGpPWpGaD
Nimodipine—CACNB1—NCAM signaling for neurite out-growth—TYK2—Crohn's disease	0.00133	0.0119	CbGpPWpGaD
Nimodipine—CACNA1F—Alzheimers Disease—TNF—Crohn's disease	0.0013	0.0116	CbGpPWpGaD
Nimodipine—CACNB3—NCAM signaling for neurite out-growth—JAK2—Crohn's disease	0.0013	0.0116	CbGpPWpGaD
Nimodipine—CACNB1—NCAM signaling for neurite out-growth—JAK2—Crohn's disease	0.00127	0.0113	CbGpPWpGaD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—TYK2—Crohn's disease	0.000973	0.00869	CbGpPWpGaD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—JAK2—Crohn's disease	0.000928	0.00829	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—PTRF—Crohn's disease	0.000911	0.00814	CbGpPWpGaD
Nimodipine—CACNB4—NCAM signaling for neurite out-growth—IL6—Crohn's disease	0.000835	0.00746	CbGpPWpGaD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—TYK2—Crohn's disease	0.000834	0.00745	CbGpPWpGaD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—JAK2—Crohn's disease	0.000796	0.00711	CbGpPWpGaD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—TYK2—Crohn's disease	0.00079	0.00706	CbGpPWpGaD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—JAK2—Crohn's disease	0.000754	0.00673	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—IL1B—Crohn's disease	0.000721	0.00644	CbGpPWpGaD
Nimodipine—AHR—Adipogenesis—STAT3—Crohn's disease	0.000701	0.00626	CbGpPWpGaD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—TYK2—Crohn's disease	0.000694	0.0062	CbGpPWpGaD
Nimodipine—CACNB3—NCAM signaling for neurite out-growth—IL6—Crohn's disease	0.000668	0.00597	CbGpPWpGaD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—JAK2—Crohn's disease	0.000662	0.00592	CbGpPWpGaD
Nimodipine—CACNB1—NCAM signaling for neurite out-growth—IL6—Crohn's disease	0.00065	0.00581	CbGpPWpGaD
Nimodipine—AHR—Adipogenesis—TNF—Crohn's disease	0.000606	0.00542	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PLA2G4F—Crohn's disease	0.000598	0.00535	CbGpPWpGaD
Nimodipine—CACNB3—Myometrial Relaxation and Contraction Pathways—IL1B—Crohn's disease	0.00059	0.00527	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—IL1B—Crohn's disease	0.000585	0.00523	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000571	0.0051	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—ZFP36L1—Crohn's disease	0.000546	0.00488	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—SMAD3—Crohn's disease	0.000536	0.00479	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—TNF—Crohn's disease	0.000523	0.00467	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—IL1B—Crohn's disease	0.000514	0.00459	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—MTMR3—Crohn's disease	0.000509	0.00455	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—TYK2—Crohn's disease	0.00049	0.00438	CbGpPWpGaD
Nimodipine—AHR—Adipogenesis—IL6—Crohn's disease	0.000489	0.00437	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—GPX4—Crohn's disease	0.000481	0.0043	CbGpPWpGaD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—IL6—Crohn's disease	0.000476	0.00425	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—JAK2—Crohn's disease	0.000467	0.00418	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—DNMT3A—Crohn's disease	0.000464	0.00415	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—SMAD3—Crohn's disease	0.000428	0.00383	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—TNF—Crohn's disease	0.000425	0.00379	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—SMAD3—Crohn's disease	0.000417	0.00372	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—SMAD3—Crohn's disease	0.000409	0.00365	CbGpPWpGaD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—IL6—Crohn's disease	0.000408	0.00365	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—FADS1—Crohn's disease	0.000396	0.00354	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—TYK2—Crohn's disease	0.000392	0.0035	CbGpPWpGaD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—IL6—Crohn's disease	0.000386	0.00345	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—TYK2—Crohn's disease	0.000381	0.0034	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—JAK2—Crohn's disease	0.000374	0.00334	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—TNF—Crohn's disease	0.000373	0.00333	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GPX4—Crohn's disease	0.000371	0.00332	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PLA2G4F—Crohn's disease	0.000365	0.00327	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—JAK2—Crohn's disease	0.000363	0.00325	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GCKR—Crohn's disease	0.000358	0.0032	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—TYK2—Crohn's disease	0.00035	0.00312	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PLA2G4F—Crohn's disease	0.000346	0.00309	CbGpPWpGaD
Nimodipine—CACNB3—Myometrial Relaxation and Contraction Pathways—IL6—Crohn's disease	0.000345	0.00309	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—IL6—Crohn's disease	0.000345	0.00309	CbGpPWpGaD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—IL6—Crohn's disease	0.000339	0.00303	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—JAK2—Crohn's disease	0.000333	0.00298	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—HSPA1B—Crohn's disease	0.000314	0.0028	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—MTMR3—Crohn's disease	0.000311	0.00278	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—SMAD3—Crohn's disease	0.000305	0.00273	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PLA2G4F—Crohn's disease	0.000304	0.00272	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—MTMR3—Crohn's disease	0.000294	0.00263	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—TYK2—Crohn's disease	0.000279	0.0025	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—TYK2—Crohn's disease	0.000279	0.00249	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—UBE2D1—Crohn's disease	0.000275	0.00246	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—TYK2—Crohn's disease	0.000272	0.00243	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—JAK2—Crohn's disease	0.000267	0.00238	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—JAK2—Crohn's disease	0.000266	0.00238	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—SMAD3—Crohn's disease	0.000262	0.00234	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—JAK2—Crohn's disease	0.000259	0.00232	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—MTMR3—Crohn's disease	0.000259	0.00231	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—SMAD3—Crohn's disease	0.000248	0.00221	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—STAT3—Crohn's disease	0.000245	0.00219	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—FADS1—Crohn's disease	0.000242	0.00216	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—IL6—Crohn's disease	0.00024	0.00214	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—TYK2—Crohn's disease	0.000239	0.00214	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—FADS1—Crohn's disease	0.000229	0.00205	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—JAK2—Crohn's disease	0.000228	0.00204	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GPX4—Crohn's disease	0.000227	0.00203	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—TYK2—Crohn's disease	0.000227	0.00202	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	0.000224	0.002	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GCKR—Crohn's disease	0.000219	0.00196	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—SMAD3—Crohn's disease	0.000218	0.00195	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—JAK2—Crohn's disease	0.000216	0.00193	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GPX4—Crohn's disease	0.000215	0.00192	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—TNF—Crohn's disease	0.000212	0.00189	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GCKR—Crohn's disease	0.000207	0.00185	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—FADS1—Crohn's disease	0.000201	0.0018	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TYK2—Crohn's disease	0.000199	0.00178	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—TYK2—Crohn's disease	0.000199	0.00178	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—SMAD3—Crohn's disease	0.000197	0.00176	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—STAT3—Crohn's disease	0.000196	0.00175	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—IL6—Crohn's disease	0.000192	0.00171	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—STAT3—Crohn's disease	0.00019	0.0017	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—JAK2—Crohn's disease	0.00019	0.0017	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—JAK2—Crohn's disease	0.00019	0.0017	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GPX4—Crohn's disease	0.000189	0.00169	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—IL6—Crohn's disease	0.000186	0.00166	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GCKR—Crohn's disease	0.000182	0.00163	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—IL6—Crohn's disease	0.000171	0.00153	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TYK2—Crohn's disease	0.000171	0.00153	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—TNF—Crohn's disease	0.000169	0.00151	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—TNF—Crohn's disease	0.000165	0.00147	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—JAK2—Crohn's disease	0.000163	0.00146	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TYK2—Crohn's disease	0.000162	0.00144	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—JAK2—Crohn's disease	0.000154	0.00138	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TYK2—Crohn's disease	0.000142	0.00127	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—STAT3—Crohn's disease	0.000139	0.00125	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—IL6—Crohn's disease	0.000137	0.00122	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—IL6—Crohn's disease	0.000136	0.00122	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—JAK2—Crohn's disease	0.000135	0.00121	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	0.000135	0.0012	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—IL6—Crohn's disease	0.000133	0.00119	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TNF—Crohn's disease	0.000121	0.00108	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—STAT3—Crohn's disease	0.00012	0.00107	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—IL6—Crohn's disease	0.000117	0.00105	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—MTMR3—Crohn's disease	0.000114	0.00102	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ALB—Crohn's disease	0.000114	0.00102	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—STAT3—Crohn's disease	0.000113	0.00101	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—IL6—Crohn's disease	0.000111	0.00099	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TNF—Crohn's disease	0.000103	0.000925	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTGS2—Crohn's disease	9.98e-05	0.000892	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—STAT3—Crohn's disease	9.95e-05	0.000889	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TNF—Crohn's disease	9.8e-05	0.000876	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—IL6—Crohn's disease	9.74e-05	0.00087	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—IL6—Crohn's disease	9.73e-05	0.00087	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—FADS1—Crohn's disease	8.92e-05	0.000797	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TNF—Crohn's disease	8.61e-05	0.000769	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—IL6—Crohn's disease	8.35e-05	0.000746	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GPX4—Crohn's disease	8.35e-05	0.000746	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GCKR—Crohn's disease	8.06e-05	0.000721	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—IL6—Crohn's disease	7.91e-05	0.000707	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ALB—Crohn's disease	6.97e-05	0.000623	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—IL6—Crohn's disease	6.95e-05	0.000621	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ALB—Crohn's disease	6.6e-05	0.00059	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	6.26e-05	0.000559	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTGS2—Crohn's disease	6.09e-05	0.000545	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ALB—Crohn's disease	5.8e-05	0.000518	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTGS2—Crohn's disease	5.77e-05	0.000516	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MTMR3—Crohn's disease	5.32e-05	0.000475	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTGS2—Crohn's disease	5.07e-05	0.000453	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—FADS1—Crohn's disease	4.14e-05	0.00037	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GPX4—Crohn's disease	3.88e-05	0.000347	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GCKR—Crohn's disease	3.75e-05	0.000335	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALB—Crohn's disease	2.57e-05	0.000229	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTGS2—Crohn's disease	2.24e-05	0.000201	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALB—Crohn's disease	1.19e-05	0.000107	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.04e-05	9.33e-05	CbGpPWpGaD
